Physician profile
Richard E Moses
NPI 1588689525
$3,622.58
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,547 · 2020: $75.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,892.90 | 2019 | |
| Daiichi Sankyo INC. | $147.47 | 2019 | |
| Boston Scientific Corporation | $98.98 | 2019 | |
| Pfizer INC. | $92.98 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $90.19 | 2019 | |
| Ironwood Pharmaceuticals, INC | $70.93 | 2019-2020 | |
| Janssen Biotech, INC. | $69.69 | 2019 | |
| Intercept Pharmaceuticals, INC. | $41.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.60 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $21.54 | 2019 | |
| Redhill Biopharma INC. | $18.02 | 2020 | |
| Gilead Sciences, INC. | $15.27 | 2020 | |
| Merck Sharp & Dohme LLC | $14.40 | 2019 | |
| Braintree Laboratories, INC. | $11.28 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Moses listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.